Zhijiang Qi
Zhijiang Qi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Chunsheng Li
Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China
4 shared publications Qiang Zhang
Department of Critical Care Medicine, Peking University Third Hospital, China
4 shared publicationsBo Liu
All authors: Department of Emergency Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
3 shared publicationsHan Yu
Emergency Department of Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
2 shared publications- Bo Liu
Department of Emergency Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China
1 shared publication Boyang Qi
1 shared publication
Latest Publications
- Open Access
- 23 May 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (5)
Development and validation of a predictive model for hospital mortality in patients with community-acquired pneumonia admitted to the intensive care unit
Objective: This retrospective cohort study aimed to develop and validate a nomogram for predicting in-hospital mortality among patients with community-acquired pneumonia admitted to the intensive care unit. Methods: Data of patients meeting the inclusion criteria were extracted from the Medical Information Mart for Intensive Care-IV database, and the patients were randomly allocated into training (n = 3798, 70%) and validation (n = 1629, 30%) cohorts. First-day intensive care unit admission parameters were averaged. Least Absolute Shrinkage and Selection Operator regression and multivariate logistic regression analyses were used to identify mortality risk factors in the training cohort, followed by nomogram construction. Model performance was evaluated based on discrimination (area under the curve), calibration (Hosmer–Lemeshow test and bootstrap resampling), and clinical utility (decision curve analysis). Data from emergency intensive care unit were used to perform external validation of the value of the model. Results: In total, 5427 patients were included. Age, red cell distribution width, Sequential Organ Failure Assessment, Acute Physiology Score-III, blood urea nitrogen-to-serum creatinine ratio, anion gap, osmolarity, and sepsis were identified as independent risk factors for hospital mortality. The nomogram demonstrated superior discrimination compared with Sequential Organ Failure Assessment and Acute Physiology Score-III in the validation (area under the curve: 0.772 vs. 0.685–0.724) and training (area under the curve: 0.787 vs. 0.708–0.740; p < 0.05) sets. Calibration and decision curve analyses confirmed robust performance (Hosmer–Lemeshow p = 0.11; net benefit threshold: 20%–80%). In both cohorts, calibration and decision curve analyses showed that the nomogram had good calibration degree, discriminative ability, and clinical benefits. Data from emergency intensive care unit showed that the area under the curve of the model was 0.7864 (95% confidence interval, 0.76–0.81), area under the curve of Sequential Organ Failure Assessment was 0.7217 (95% confidence interval, 0.69–0.75), and area under the curve of Acute Physiology Score-III was 0.7055 (95% confidence interval, 0.68–0.73). Conclusions: This nomogram provides moderate predictive accuracy for hospital mortality in critically ill patients with community-acquired pneumonia and may aid prognosis assessment.
- 23 May 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (5)
Open AccessDevelopment and validation of a predictive model for hospital mortality in patients with community-acquired pneumonia admitted to the intensive care unit
Objective: This retrospective cohort study aimed to develop and validate a nomogram for predicting in-hospital mortality among patients with community-acquired pneumonia admitted to the intensive care unit. Methods: Data of patients meeting the inclusion criteria were extracted from the Medical Information Mart for Intensive Care-IV database, and the patients were randomly allocated into training (n = 3798, 70%) and validation (n = 1629, 30%) cohorts. First-day intensive care unit admission parameters were averaged. Least Absolute Shrinkage and Selection Operator regression and multivariate logistic regression analyses were used to identify mortality risk factors in the training cohort, followed by nomogram construction. Model performance was evaluated based on discrimination (area under the curve), calibration (Hosmer–Lemeshow test and bootstrap resampling), and clinical utility (decision curve analysis). Data from emergency intensive care unit were used to perform external validation of the value of the model. Results: In total, 5427 patients were included. Age, red cell distribution width, Sequential Organ Failure Assessment, Acute Physiology Score-III, blood urea nitrogen-to-serum creatinine ratio, anion gap, osmolarity, and sepsis were identified as independent risk factors for hospital mortality. The nomogram demonstrated superior discrimination compared with Sequential Organ Failure Assessment and Acute Physiology Score-III in the validation (area under the curve: 0.772 vs. 0.685–0.724) and training (area under the curve: 0.787 vs. 0.708–0.740; p < 0.05) sets. Calibration and decision curve analyses confirmed robust performance (Hosmer–Lemeshow p = 0.11; net benefit threshold: 20%–80%). In both cohorts, calibration and decision curve analyses showed that the nomogram had good calibration degree, discriminative ability, and clinical benefits. Data from emergency intensive care unit showed that the area under the curve of the model was 0.7864 (95% confidence interval, 0.76–0.81), area under the curve of Sequential Organ Failure Assessment was 0.7217 (95% confidence interval, 0.69–0.75), and area under the curve of Acute Physiology Score-III was 0.7055 (95% confidence interval, 0.68–0.73). Conclusions: This nomogram provides moderate predictive accuracy for hospital mortality in critically ill patients with community-acquired pneumonia and may aid prognosis assessment.
- Open Access
- 22 May 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (6) , 665
Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients
Aims: The pharmacokinetic (PK) profiles of voriconazole in intensive care unit (ICU) patients differ from that in other patients. We aimed to develop a population pharmacokinetic (PopPK) model to evaluate the effects of using extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) and those of various biological covariates on the voriconazole PK profile. Methods: Modeling analyses of the PK parameters were conducted using the nonlinear mixed-effects modeling method (NONMEM) with a two-compartment model. Monte Carlo simulations (MCSs) were performed to observe the probability of target attainment (PTA) when receiving CRRT or not under different dosage regimens, different stratifications of quick C-reactive protein (qCRP), and different minimum inhibitory concentration (MIC) ranges. Results: A total of 408 critically ill patients with 746 voriconazole concentration–time data points were included in this study. A two-compartment population PK model with qCRP, CRRT, creatinine clearance rate (CLCR), platelets (PLT), and prothrombin time (PT) as fixed effects was developed using the NONMEM. Conclusions: We found that qCRP, CRRT, CLCR, PLT, and PT affected the voriconazole clearance. The most commonly used clinical regimen of 200 mg q12h was sufficient for the most common sensitive pathogens (MIC ≤ 0.25 mg/L), regardless of whether CRRT was performed and the level of qCRP. When the MIC was 0.5 mg/L, 200 mg q12h was insufficient only when the qCRP was <40 mg/L and CRRT was performed. When the MIC was ≥2 mg/L, a dose of 300 mg q12h could not achieve ≥ 90% PTA, necessitating the evaluation of a higher dose.
- 22 May 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (6) , 665
Open AccessRenal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients
Aims: The pharmacokinetic (PK) profiles of voriconazole in intensive care unit (ICU) patients differ from that in other patients. We aimed to develop a population pharmacokinetic (PopPK) model to evaluate the effects of using extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) and those of various biological covariates on the voriconazole PK profile. Methods: Modeling analyses of the PK parameters were conducted using the nonlinear mixed-effects modeling method (NONMEM) with a two-compartment model. Monte Carlo simulations (MCSs) were performed to observe the probability of target attainment (PTA) when receiving CRRT or not under different dosage regimens, different stratifications of quick C-reactive protein (qCRP), and different minimum inhibitory concentration (MIC) ranges. Results: A total of 408 critically ill patients with 746 voriconazole concentration–time data points were included in this study. A two-compartment population PK model with qCRP, CRRT, creatinine clearance rate (CLCR), platelets (PLT), and prothrombin time (PT) as fixed effects was developed using the NONMEM. Conclusions: We found that qCRP, CRRT, CLCR, PLT, and PT affected the voriconazole clearance. The most commonly used clinical regimen of 200 mg q12h was sufficient for the most common sensitive pathogens (MIC ≤ 0.25 mg/L), regardless of whether CRRT was performed and the level of qCRP. When the MIC was 0.5 mg/L, 200 mg q12h was insufficient only when the qCRP was <40 mg/L and CRRT was performed. When the MIC was ≥2 mg/L, a dose of 300 mg q12h could not achieve ≥ 90% PTA, necessitating the evaluation of a higher dose.
- Open Access
- 10 October 2023
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 51 (10)
The effect of nebulized heparin on clinical outcomes in mechanically ventilated patients: a meta-analysis and review of the literature
Objective: To determine the relationship between use of nebulized heparin and clinical outcomes in mechanically ventilated patients. Methods: The Medline, Embase, Web of Science, Cochrane Library, and PubMed databases were searched for relevant randomized controlled trials (RCTs), published between database inception and May 2022. Primary outcomes were intensive care unit (ICU) length of stay and in-hospital mortality; secondary outcomes included duration of mechanical ventilation, ventilator-free days (VFDs) in 28 days, and length of hospitalization. The study protocol was registered on PROSPERO (registration No: CRD42022345533). Results: A total of eight RCTs (651 patients) were included. Nebulized heparin was associated with reduced ICU length of stay (six studies; mean difference [MD] –1.10, 95% confidence interval [CI] –1.87, –0.33, I2 = 76%), reduced duration of mechanical ventilation (two studies; MD –2.63, 95% CI –3.68, –1.58, I2 = 92%) and increased VFDs in 28 days (two studies; MD 4.22, 95% CI 1.10, 7.35, I2 = 18%), without increased incidence of adverse events, such as bleeding; but was not associated with a reduction in length of hospitalization (three studies; MD –1.00, 95% CI –2.90, –0.90, I2 = 0%) or in-hospital mortality (five studies; odds ratio 1.10, 95% CI 0.69, 1.77, I2 = 0%). Conclusion: Nebulized heparin reduces ICU length of stay and duration of mechanical ventilation in mechanically ventilated patients, but has no effect on length of hospitalization or mortality.
- 10 October 2023
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 51 (10)
Open AccessThe effect of nebulized heparin on clinical outcomes in mechanically ventilated patients: a meta-analysis and review of the literature
Objective: To determine the relationship between use of nebulized heparin and clinical outcomes in mechanically ventilated patients. Methods: The Medline, Embase, Web of Science, Cochrane Library, and PubMed databases were searched for relevant randomized controlled trials (RCTs), published between database inception and May 2022. Primary outcomes were intensive care unit (ICU) length of stay and in-hospital mortality; secondary outcomes included duration of mechanical ventilation, ventilator-free days (VFDs) in 28 days, and length of hospitalization. The study protocol was registered on PROSPERO (registration No: CRD42022345533). Results: A total of eight RCTs (651 patients) were included. Nebulized heparin was associated with reduced ICU length of stay (six studies; mean difference [MD] –1.10, 95% confidence interval [CI] –1.87, –0.33, I2 = 76%), reduced duration of mechanical ventilation (two studies; MD –2.63, 95% CI –3.68, –1.58, I2 = 92%) and increased VFDs in 28 days (two studies; MD 4.22, 95% CI 1.10, 7.35, I2 = 18%), without increased incidence of adverse events, such as bleeding; but was not associated with a reduction in length of hospitalization (three studies; MD –1.00, 95% CI –2.90, –0.90, I2 = 0%) or in-hospital mortality (five studies; odds ratio 1.10, 95% CI 0.69, 1.77, I2 = 0%). Conclusion: Nebulized heparin reduces ICU length of stay and duration of mechanical ventilation in mechanically ventilated patients, but has no effect on length of hospitalization or mortality.
- Open Access
- 1 January 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 133, 111026
Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome
- 1 January 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 133, 111026
Open AccessAlveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome
- 1 July 2019
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 47 (7) , e538-e546
Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous Circulation
Objectives: After return of spontaneous circulation, patients who experienced out-of-hospital cardiac arrest present an impaired innate immune response that resembles sepsis. Presepsin, a new biomarker for sepsis, has not been studied in out-of-hospital cardiac arrest patients. This study explored the role of presepsin in evaluating the prognosis and early innate immune alteration of out-of-hospital cardiac arrest patients after return of spontaneous circulation by observing presepsin levels, CD14, and human leukocyte antigen-DR expression on monocytes. Design: Retrospective analysis. Setting: The emergency department of an urban university tertiary hospital. Participants: One hundred sixty-five out-of-hospital cardiac arrest patients with return of spontaneous circulation more than 12 hours, and 100 healthy individuals. Interventions: None. Measurements and Main Results: Plasma presepsin and procalcitonin levels were tested after resuscitation (day 0) and on days 1 and 3 after return of spontaneous circulation. Presepsin levels were higher in out-of-hospital cardiac arrest patients than in healthy individuals. In the first 3 days, presepsin and procalcitonin levels were persistently lower in 28-day survivors and patients with favorable neurologic outcome patients than in 28-day nonsurvivors and patients with unfavorable neurologic outcome. On days 0, 1, and 3, different cut-off values of presepsin showed prognostic value for 28-day mortality and favorable neurologic outcomes similar to procalcitonin. CD14 and human leukocyte antigen-DR expression on monocytes were analyzed by flow cytometry. Compared with controls, CD14 expression in out-of-hospital cardiac arrest patients increased on day 1 and began to decrease on day 3, whereas human leukocyte antigen-DR+ monocyte percentages decreased on days 1 and 3. Presepsin and procalcitonin had a low positive correlation with CD14 expression and a strong negative correlation with human leukocyte antigen-DR+ monocyte percentages on day 1. Conclusions: Plasma presepsin concentrations are independent prognostic factors for out-of-hospital cardiac arrest patients after return of spontaneous circulation and are correlated with abnormal CD14 and human leukocyte antigen-DR expression on monocytes. Monitoring presepsin levels may be helpful for evaluating the prognosis and impaired innate immune response in the early period after return of spontaneous circulation.
- 1 July 2019
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 47 (7) , e538-e546
Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous Circulation
Objectives: After return of spontaneous circulation, patients who experienced out-of-hospital cardiac arrest present an impaired innate immune response that resembles sepsis. Presepsin, a new biomarker for sepsis, has not been studied in out-of-hospital cardiac arrest patients. This study explored the role of presepsin in evaluating the prognosis and early innate immune alteration of out-of-hospital cardiac arrest patients after return of spontaneous circulation by observing presepsin levels, CD14, and human leukocyte antigen-DR expression on monocytes. Design: Retrospective analysis. Setting: The emergency department of an urban university tertiary hospital. Participants: One hundred sixty-five out-of-hospital cardiac arrest patients with return of spontaneous circulation more than 12 hours, and 100 healthy individuals. Interventions: None. Measurements and Main Results: Plasma presepsin and procalcitonin levels were tested after resuscitation (day 0) and on days 1 and 3 after return of spontaneous circulation. Presepsin levels were higher in out-of-hospital cardiac arrest patients than in healthy individuals. In the first 3 days, presepsin and procalcitonin levels were persistently lower in 28-day survivors and patients with favorable neurologic outcome patients than in 28-day nonsurvivors and patients with unfavorable neurologic outcome. On days 0, 1, and 3, different cut-off values of presepsin showed prognostic value for 28-day mortality and favorable neurologic outcomes similar to procalcitonin. CD14 and human leukocyte antigen-DR expression on monocytes were analyzed by flow cytometry. Compared with controls, CD14 expression in out-of-hospital cardiac arrest patients increased on day 1 and began to decrease on day 3, whereas human leukocyte antigen-DR+ monocyte percentages decreased on days 1 and 3. Presepsin and procalcitonin had a low positive correlation with CD14 expression and a strong negative correlation with human leukocyte antigen-DR+ monocyte percentages on day 1. Conclusions: Plasma presepsin concentrations are independent prognostic factors for out-of-hospital cardiac arrest patients after return of spontaneous circulation and are correlated with abnormal CD14 and human leukocyte antigen-DR expression on monocytes. Monitoring presepsin levels may be helpful for evaluating the prognosis and impaired innate immune response in the early period after return of spontaneous circulation.
- Open Access
- 5 September 2018
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 131 (17) , 2071-2079
Early Changes in Circulatory T Helper Type 1, 2, and 17 Cells of Patients with Out-of-Hospital Cardiac Arrest after Successful Cardiopulmonary Resuscitation
Background: Immune disorder is an important feature of patients with out-of-hospital cardiac arrest (OHCA) after the return of spontaneous circulation (ROSC). We investigated the expression of circulatory T helper type (Th) 1, Th2, and Th17 cells to explore the early immune alteration in OHCA patients after ROSC. Methods: During July–September 2016 and March–September 2017, 65 consecutive OHCA patients with ROSC?>12 h and 30 healthy individuals were enrolled in this study. Clinical and 28-day survival data were collected. Peripheral blood samples were analyzed to evaluate the expression of Th1/Th2/Th17 cells by flow cytometry from OHCA patients after ROSC on days 1 and 3 and from healthy individuals. Results: Compared with healthy individuals, T lymphocyte counts and Th1 cell counts decreased on days 1 and 3 after ROSC (1464 [1198, 2152] vs. 779 [481, 1140] vs. 581 [324, 1118]/μl, χ2 = 30.342, P < 0.001; 154 [90, 246] vs. 39 [19, 78] vs. 24 [12, 53]/μl, χ2 = 42.880, P < 0.001), and Th2 and Th17 cell counts decreased on day 3 (17.0 [10.8, 24.0] vs. 9.0 [3.0, 15.5]/μl, Z = –3.228, P = 0.001; 4.7 [2.7, 9.1] vs. 2.7 [1.0, 6.5]/μl, Z = –2.294, P = 0.022). No change in CD4+/CD3+ lymphocyte ratio was seen on day 1 or day 3 (57.9 [49.4, 63.0] vs. 55.4 [46.5, 66.5] vs. 55.4 [50.2, 67.0]%, χ2 = 0.171, P = 0.918). Th1/CD4+ lymphocyte ratio decreased on days 1 and 3 (19.0 [14.0, 24.9] vs. 9.3 [4.6, 13.9] vs. 9.5 [4.9, 13.6]%, χ2 = 25.754, P < 0.001), and Th2/CD4+ lymphocyte ratio increased on day 1 and decreased on day 3 (1.9 [1.2, 2.5] vs. 2.5 [1.6, 4.0] vs. 1.9 [1.6, 3.8]%, χ2 = 6.913, P = 0.032). Th1/Th2 cell ratio also decreased on both days (9.4 [7.3, 13.5] vs. 3.1 [1.9, 5.6] vs. 4.2 [2.8, 5.9], χ2 = 44.262, P < 0.001). Despite an upward trend in the median of Th17/CD4+ lymphocyte ratio in OHCA patients, there was no significant difference compared with healthy individuals (0.9 [0.4, 1.2] vs. 0.7 [0.4, 1.2] vs. 0.6 [0.3, 1.0]%, χ2 = 2.620, P = 0.270). The dynamic expression of Th1/Th2/Th17 cells on days 1 and 3 were simultaneously analyzed in 28/53 OHCA patients who survived >3 days; patients were divided into survivors (n = 10) and nonsurvivors (n = 18) based on 28-day survival. No significant differences in Th1/Th2/Th17 cell counts, ratios in CD4+ lymphocytes, and Th1/Th2 cell ratio were seen between survivors and nonsurvivors on both days (all P > 0.05). There was no difference over time in both survivors and nonsurvivors (all P > 0.05). Conclusion: Downregulated T lymphocyte counts, including Th1/Th2/Th17 subsets and Th1/Th2 cell ratio imbalance, occur in the early period after ROSC, that may be involved in immune dysfunction in OHCA patients. 院外心跳骤停患者心肺复苏成功后早期阶段循环中 Th1 、 Th2 及 Th17 细胞的变化 摘要 背景:免疫紊乱是院外心跳骤停(out-of-hospital cardiac arrest,OHCA)患者恢复自主循环(return of spontaneous circulation,ROSC)后的一个重要特征。在本研究中,我们观察了循环辅助性T细胞(T helper type 1,Th1)、Th2及Th17细胞的表达,以探讨OHCA患者ROSC后早期免疫功能改变。 方法:从2016年7月至9月及2017年3月至9月,共收集65名恢复自主循环超过12小时的OHCA患者及30名健康对照者,收集患者临床及28天生存数据。通过流式细胞术分析OHCA患者恢复自主循环后第1、3天及健康对照者外周血中Th1、Th2及Th17细胞的表达。 结果:与健康对照组相比,在ROSC后的第1天及3天,T淋巴细胞及Th1细胞计数降低,在第3天Th2及Th17细胞计数降低。在第1天及第3天,CD4+/CD3+ 淋巴细胞比例无明显改变。尽管如此,在第1天及第3天Th1/CD4+ 淋巴细胞比例降低,Th2/CD4+淋巴细胞比例在第1天升高,第3天开始下降。Th1/Th2 比例在第1天及第3天同样降低。尽管在OHCA患者Th17/CD4+ 淋巴细胞比例呈现上升趋势,但与健康对照比较无统计学差异。53名存活超过3天的患者中,有28名患者同时分析了第1天及第3天Th1、Th2及Th17细胞的动态表达,按照28天的生存结局分为生存者(n=10)及非生存者(n=18)。在第1天及第3天,Th1、Th2及Th17细胞计数及其在CD4+淋巴细胞的比例以及Th1/Th2比例在生存者及非生存者之间未见差异。同样,在生存者与非生存者,未见上述指标随时间的变化。 结论:下调的T淋巴细胞计数包括Th1、Th2及Th17细胞亚群及失衡的Th1/Th2比例发生在ROSC后早期阶段,这可能参与了OHCA患者ROSC后的免疫功能失调。
- 5 September 2018
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 131 (17) , 2071-2079
Open AccessEarly Changes in Circulatory T Helper Type 1, 2, and 17 Cells of Patients with Out-of-Hospital Cardiac Arrest after Successful Cardiopulmonary Resuscitation
Background: Immune disorder is an important feature of patients with out-of-hospital cardiac arrest (OHCA) after the return of spontaneous circulation (ROSC). We investigated the expression of circulatory T helper type (Th) 1, Th2, and Th17 cells to explore the early immune alteration in OHCA patients after ROSC. Methods: During July–September 2016 and March–September 2017, 65 consecutive OHCA patients with ROSC?>12 h and 30 healthy individuals were enrolled in this study. Clinical and 28-day survival data were collected. Peripheral blood samples were analyzed to evaluate the expression of Th1/Th2/Th17 cells by flow cytometry from OHCA patients after ROSC on days 1 and 3 and from healthy individuals. Results: Compared with healthy individuals, T lymphocyte counts and Th1 cell counts decreased on days 1 and 3 after ROSC (1464 [1198, 2152] vs. 779 [481, 1140] vs. 581 [324, 1118]/μl, χ2 = 30.342, P < 0.001; 154 [90, 246] vs. 39 [19, 78] vs. 24 [12, 53]/μl, χ2 = 42.880, P < 0.001), and Th2 and Th17 cell counts decreased on day 3 (17.0 [10.8, 24.0] vs. 9.0 [3.0, 15.5]/μl, Z = –3.228, P = 0.001; 4.7 [2.7, 9.1] vs. 2.7 [1.0, 6.5]/μl, Z = –2.294, P = 0.022). No change in CD4+/CD3+ lymphocyte ratio was seen on day 1 or day 3 (57.9 [49.4, 63.0] vs. 55.4 [46.5, 66.5] vs. 55.4 [50.2, 67.0]%, χ2 = 0.171, P = 0.918). Th1/CD4+ lymphocyte ratio decreased on days 1 and 3 (19.0 [14.0, 24.9] vs. 9.3 [4.6, 13.9] vs. 9.5 [4.9, 13.6]%, χ2 = 25.754, P < 0.001), and Th2/CD4+ lymphocyte ratio increased on day 1 and decreased on day 3 (1.9 [1.2, 2.5] vs. 2.5 [1.6, 4.0] vs. 1.9 [1.6, 3.8]%, χ2 = 6.913, P = 0.032). Th1/Th2 cell ratio also decreased on both days (9.4 [7.3, 13.5] vs. 3.1 [1.9, 5.6] vs. 4.2 [2.8, 5.9], χ2 = 44.262, P < 0.001). Despite an upward trend in the median of Th17/CD4+ lymphocyte ratio in OHCA patients, there was no significant difference compared with healthy individuals (0.9 [0.4, 1.2] vs. 0.7 [0.4, 1.2] vs. 0.6 [0.3, 1.0]%, χ2 = 2.620, P = 0.270). The dynamic expression of Th1/Th2/Th17 cells on days 1 and 3 were simultaneously analyzed in 28/53 OHCA patients who survived >3 days; patients were divided into survivors (n = 10) and nonsurvivors (n = 18) based on 28-day survival. No significant differences in Th1/Th2/Th17 cell counts, ratios in CD4+ lymphocytes, and Th1/Th2 cell ratio were seen between survivors and nonsurvivors on both days (all P > 0.05). There was no difference over time in both survivors and nonsurvivors (all P > 0.05). Conclusion: Downregulated T lymphocyte counts, including Th1/Th2/Th17 subsets and Th1/Th2 cell ratio imbalance, occur in the early period after ROSC, that may be involved in immune dysfunction in OHCA patients. 院外心跳骤停患者心肺复苏成功后早期阶段循环中 Th1 、 Th2 及 Th17 细胞的变化 摘要 背景:免疫紊乱是院外心跳骤停(out-of-hospital cardiac arrest,OHCA)患者恢复自主循环(return of spontaneous circulation,ROSC)后的一个重要特征。在本研究中,我们观察了循环辅助性T细胞(T helper type 1,Th1)、Th2及Th17细胞的表达,以探讨OHCA患者ROSC后早期免疫功能改变。 方法:从2016年7月至9月及2017年3月至9月,共收集65名恢复自主循环超过12小时的OHCA患者及30名健康对照者,收集患者临床及28天生存数据。通过流式细胞术分析OHCA患者恢复自主循环后第1、3天及健康对照者外周血中Th1、Th2及Th17细胞的表达。 结果:与健康对照组相比,在ROSC后的第1天及3天,T淋巴细胞及Th1细胞计数降低,在第3天Th2及Th17细胞计数降低。在第1天及第3天,CD4+/CD3+ 淋巴细胞比例无明显改变。尽管如此,在第1天及第3天Th1/CD4+ 淋巴细胞比例降低,Th2/CD4+淋巴细胞比例在第1天升高,第3天开始下降。Th1/Th2 比例在第1天及第3天同样降低。尽管在OHCA患者Th17/CD4+ 淋巴细胞比例呈现上升趋势,但与健康对照比较无统计学差异。53名存活超过3天的患者中,有28名患者同时分析了第1天及第3天Th1、Th2及Th17细胞的动态表达,按照28天的生存结局分为生存者(n=10)及非生存者(n=18)。在第1天及第3天,Th1、Th2及Th17细胞计数及其在CD4+淋巴细胞的比例以及Th1/Th2比例在生存者及非生存者之间未见差异。同样,在生存者与非生存者,未见上述指标随时间的变化。 结论:下调的T淋巴细胞计数包括Th1、Th2及Th17细胞亚群及失衡的Th1/Th2比例发生在ROSC后早期阶段,这可能参与了OHCA患者ROSC后的免疫功能失调。
- 29 December 2017
- Published by Elsevier in Clinica Chimica Acta
- Vol. 478, 152-156
Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia
- 29 December 2017
- Published by Elsevier in Clinica Chimica Acta
- Vol. 478, 152-156
Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia
- 1 June 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (6) , 835-841
Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis
- 1 June 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (6) , 835-841
Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis